Print Page  |  Close Window

SEC Filings

8-K
CHROMADEX CORP. filed this Form 8-K on 03/07/2019
Entire Document
 
 
 
 
Investor Conference Call
 
ChromaDex management will host an investor conference call to discuss the year end results and provide a general business update on Thursday, March 7, at 4:30pm ET.
 
Participants should call in at least 10 minutes prior to the call. The dial-in information is as follows:
 
Date: Thursday, March 7, 2019
 
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
 
Toll-free dial-in number: 1-866-327-8118
 
International dial-in number: 1-678-509-7526
 
Conference ID: 5675308
 
Webcast link: https://edge.media-server.com/m6/p/h5vfpb7m
 
The webcast replay will be available after the completion of the call on the Investor Relations section of the Company website, www.chromadex.com.
 
The earnings press release, and its accompanying financial exhibits, will be available on the Investor Relations section of the Company website, www.chromadex.com.
 
About ChromaDex:
 
ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.
 
 
 
-3-